NEVVI Medicare utilization intelligence
or

← back

Provider profile

POSNIK, BARTLOMIEJ M.D.

Medical Oncology · NPI 1609286251 · BASTROP, TX

1
Groups
57
Codes · 2024
72,998
Disclosed services

POSNIK, BARTLOMIEJ is a Medical Oncology in BASTROP, TX, a member of 1 medical group, who billed 57 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider analytics (2024)

POSNIK, BARTLOMIEJ billed 92,340 disclosed services in CY2023 and 72,998 in CY2024.

This provider's disclosed Medicare payments across all codes were $ in CY2024.

The full figure is part of the market analytics platform — built, not launched yet. Notify me at launch →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
82784 Gammaglobulin (immune system protein) measurement
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
83521 Measurement of immunoglobulin light chains
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96372 Injection of drug or substance under skin or into muscle
83615 Lactate dehydrogenase (enzyme) level
96413 Administration of chemotherapy into vein, 1 hour or less
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J3489 Injection, zoledronic acid, 1 mg
96375 Injection of additional new drug or substance into vein
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J3475 Injection, magnesium sulfate, per 500 mg
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
85055 Reticulated (young) platelet measurement
J7030 Infusion, normal saline solution , 1000 cc
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
85045 Red blood count, automated test
96417 Administration of additional new drug or substance into vein, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96415 Administration of chemotherapy into vein, each additional hour
83735 Magnesium level
96360 Infusion into a vein for hydration, 31-60 minutes
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
82378 Carcinoembryonic antigen (cea) protein level
96361 Infusion into a vein for hydration, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
96411 Administration of additional new drug or substance into vein using push technique
84153 Psa (prostate specific antigen) measurement, total
99195 Drawing of blood for a medical problem
96523 Irrigation of implanted venous access drug delivery device
96374 Injection of drug or substance into vein
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
83010 Haptoglobin (serum protein) level
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.